Corrigendum to “Phase III trials in ovarian cancer: The evolving landscape of front line therapy” [Gynecol. Oncol. 153 (2019) 436–444](S0090825819301131)(10.1016/j.ygyno.2019.02.008)

R. Wendel Naumann; Robert L. Coleman; Jubilee Brown; Kathleen N. Moore

doi:10.1016/j.ygyno.2019.12.007

Corrigendum to “Phase III trials in ovarian cancer: The evolving landscape of front line therapy” [Gynecol. Oncol. 153 (2019) 436–444](S0090825819301131)(10.1016/j.ygyno.2019.02.008)

R. Wendel Naumann, Robert L. Coleman, Jubilee Brown, Kathleen N. Moore

Gynecological Oncology & Reproductive Medicine

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

The authors regret that there were some errors in the original Tables 1 and 2. The correct versions of the tables can be found below. The authors would like to apologise for any inconvenience caused.

Original language	English (US)
Pages (from-to)	512-513
Number of pages	2
Journal	Gynecologic oncology
Volume	156
Issue number	2
DOIs	https://doi.org/10.1016/j.ygyno.2019.12.007
State	Published - Feb 2020

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/j.ygyno.2019.12.007

Cite this

Corrigendum to “Phase III trials in ovarian cancer: The evolving landscape of front line therapy” [Gynecol. Oncol. 153 (2019) 436–444](S0090825819301131)(10.1016/j.ygyno.2019.02.008). / Naumann, R. Wendel; Coleman, Robert L.; Brown, Jubilee et al.
In: Gynecologic oncology, Vol. 156, No. 2, 02.2020, p. 512-513.

Research output: Contribution to journal › Comment/debate › peer-review

@article{1013139babc04f75855ba60c0b9c7525,

title = "Corrigendum to “Phase III trials in ovarian cancer: The evolving landscape of front line therapy” [Gynecol. Oncol. 153 (2019) 436–444](S0090825819301131)(10.1016/j.ygyno.2019.02.008)",

abstract = "The authors regret that there were some errors in the original Tables 1 and 2. The correct versions of the tables can be found below. The authors would like to apologise for any inconvenience caused.",

author = "Naumann, {R. Wendel} and Coleman, {Robert L.} and Jubilee Brown and Moore, {Kathleen N.}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2020",

month = feb,

doi = "10.1016/j.ygyno.2019.12.007",

language = "English (US)",

volume = "156",

pages = "512--513",

journal = "Gynecologic oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "2",

}

TY - JOUR

T1 - Corrigendum to “Phase III trials in ovarian cancer

T2 - The evolving landscape of front line therapy” [Gynecol. Oncol. 153 (2019) 436–444](S0090825819301131)(10.1016/j.ygyno.2019.02.008)

AU - Naumann, R. Wendel

AU - Coleman, Robert L.

AU - Brown, Jubilee

AU - Moore, Kathleen N.

PY - 2020/2

Y1 - 2020/2

N2 - The authors regret that there were some errors in the original Tables 1 and 2. The correct versions of the tables can be found below. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that there were some errors in the original Tables 1 and 2. The correct versions of the tables can be found below. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85076561509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076561509&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2019.12.007

DO - 10.1016/j.ygyno.2019.12.007

M3 - Comment/debate

C2 - 31859001

AN - SCOPUS:85076561509

SN - 0090-8258

VL - 156

SP - 512

EP - 513

JO - Gynecologic oncology

JF - Gynecologic oncology

IS - 2

ER -

Corrigendum to “Phase III trials in ovarian cancer: The evolving landscape of front line therapy” [Gynecol. Oncol. 153 (2019) 436–444](S0090825819301131)(10.1016/j.ygyno.2019.02.008)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this